JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RARE - Ultragenyx Pharmaceutical Inc.
USD | NASDAQ | Healthcare
Summary
Summary RARE Stock
Financials
Financials RARE Stock
Loading...
Loading...
Income Statement
Income Statement RARE Stock
Balance Sheet
Balance Sheet RARE Stock
Cash Flow Statement
Cash Flow Statement RARE Stock
Loading...
Loading...
RARE Financials - Ultragenyx Pharmaceutical Income & Cash Flow | Ledgeburg
Home
Stocks
Ultragenyx Pharmaceutical Inc. (RARE)
Financials
Financials of RARE
Loading...
Loading...
Loading...
Loading...
Revenue
$673M
Operating Income
$-535M
Net Income
$-575M
Share Count (Basic)
98.6M
Operating Cash Flow
$-466M
Free Cash Flow
$-472M
Cash And Short-Term Equivalents
$421M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-700M
-650M
-600M
-550M
-500M
-450M
Annual
Quarterly
Margins
Gross
Operating
Net
-200%
-150%
-100%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-180M
-160M
-140M
-120M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-140%
-120%
-100%
-80%
-60%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26